CDK4 and neutropenia: As a representative agent of CDK4/6 inhibitors, ribociclib demonstrates common adverse reactions including hepatotoxicity (10), neutropenia, thrombocytopenia, QT interval prolongation, gastrointestinal disturbances such as nausea, diarrhea, and vomiting, along with fatigue (11).